Meditor Group’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-435,000
Closed -$54.2M 32
2013
Q3
$54.2M Sell
435,000
-527,103
-55% -$66.7M 7.65% 3
2013
Q2
$83.5M Buy
+962,103
New +$88.6M 11.31% 2

Meditor Group's ONXX Position: Q4 2013 in Review

Meditor Group sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 435,000 shares — an estimated $54.2M sold.

Meditor Group first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $83.5M in Q2 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • Meditor Group reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Meditor Group sold 435,000 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $54.2M.
  • Meditor Group first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Meditor Group's ONYX PHARMACEUTICALS INC position peaked at $83.5M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on Meditor Group's 13F filing for Q4 2013, filed 21 Jan 2014.